-
Changes are coming in 2025 to the federal healh insurance program that covers Americans age 65 and older. Two Medicare experts spoke on "The Florida Roundup" about what to expect.
-
CMS finally accepted Florida’s application for a waiver, but with the stipulation that the state provides 12 months of continuous coverage. But the state doesn't want to accept the agency's requirements.
-
Two academic health care policy experts break down Medicare Advantage, which was supposed to save the government money. Instead, the payment rules overpay insurance companies on the taxpayers' dime.
-
The federal government put guardrails in place to limit unauthorized plan sign-ups and switches. But the changes could prove to be a burden to consumers.
-
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans. But it’s unclear if it will will have support of the Trump administration.
-
Medicare officials defend the use of home visits that often spot medical conditions that are never treated.
-
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
-
The open enrollment period began Tuesday and runs through Dec. 7 for 2025 benefits. An AARP drug policy expert says prescription plans are going to be more generous than before.
-
New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in overcharges. What is the Centers for Medicare & Medicaid Services doing about it?
-
Federal regulators provided more specifics about why they suspended two private sector sites, including concerns about potential overseas accessing of consumer data and suspicions of involvement in enrollment and switching schemes.